Dino Luethi

1.7k total citations
47 papers, 1.2k citations indexed

About

Dino Luethi is a scholar working on Clinical Psychology, Cellular and Molecular Neuroscience and Toxicology. According to data from OpenAlex, Dino Luethi has authored 47 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Clinical Psychology, 28 papers in Cellular and Molecular Neuroscience and 18 papers in Toxicology. Recurrent topics in Dino Luethi's work include Psychedelics and Drug Studies (32 papers), Neurotransmitter Receptor Influence on Behavior (28 papers) and Forensic Toxicology and Drug Analysis (18 papers). Dino Luethi is often cited by papers focused on Psychedelics and Drug Studies (32 papers), Neurotransmitter Receptor Influence on Behavior (28 papers) and Forensic Toxicology and Drug Analysis (18 papers). Dino Luethi collaborates with scholars based in Switzerland, Austria and United States. Dino Luethi's co-authors include Matthias E. Liechti, Marius C. Hoener, Stephan Krähenbühl, Anna Rickli, Karolina E. Kolaczynska, Deborah Rudin, Urs Duthaler, Harald H. Sitte, Isabelle Straumann and Aaron Klaiber and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and International Journal of Molecular Sciences.

In The Last Decade

Dino Luethi

43 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dino Luethi Switzerland 20 740 647 531 290 242 47 1.2k
Anna Rickli Switzerland 12 822 1.1× 707 1.1× 652 1.2× 227 0.8× 179 0.7× 15 1.2k
Jason Wallach United States 21 780 1.1× 636 1.0× 379 0.7× 367 1.3× 216 0.9× 32 1.2k
João Paulo Capela Portugal 22 416 0.6× 775 1.2× 794 1.5× 48 0.2× 297 1.2× 53 1.6k
Nicholas V. Cozzi United States 22 1.5k 2.0× 1.4k 2.2× 1.2k 2.2× 571 2.0× 736 3.0× 43 2.6k
Jakub Wojcieszak Poland 15 233 0.3× 250 0.4× 436 0.8× 71 0.2× 276 1.1× 27 854
Eulàlia Olesti Spain 16 175 0.2× 146 0.2× 249 0.5× 113 0.4× 202 0.8× 28 713
Spyros P. Nikas United States 24 129 0.2× 767 1.2× 176 0.3× 227 0.8× 595 2.5× 82 1.9k
York Schramm Switzerland 6 389 0.5× 412 0.6× 546 1.0× 589 2.0× 179 0.7× 6 1.2k
Herbert H. Seltzman United States 27 129 0.2× 1.1k 1.7× 261 0.5× 281 1.0× 836 3.5× 82 2.2k
David L. Nelson United States 17 217 0.3× 443 0.7× 98 0.2× 318 1.1× 368 1.5× 23 852

Countries citing papers authored by Dino Luethi

Since Specialization
Citations

This map shows the geographic impact of Dino Luethi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dino Luethi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dino Luethi more than expected).

Fields of papers citing papers by Dino Luethi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dino Luethi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dino Luethi. The network helps show where Dino Luethi may publish in the future.

Co-authorship network of co-authors of Dino Luethi

This figure shows the co-authorship network connecting the top 25 collaborators of Dino Luethi. A scholar is included among the top collaborators of Dino Luethi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dino Luethi. Dino Luethi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thomann, Jan, Deborah Rudin, Sarah Kraus, et al.. (2025). Liquid chromatography–tandem mass spectrometry–based pharmacokinetic and metabolic analysis of 4-bromo-2,5-dimethoxyphenethylamine and its metabolites in human plasma. Drug Metabolism and Disposition. 53(6). 100086–100086. 2 indexed citations
2.
Klaiber, Aaron, Laura Ley, A. Becker, et al.. (2025). Pharmacokinetics, Pharmacodynamics, and Urinary Recovery of Oral Mescaline Hydrochloride in Healthy Participants. Clinical Pharmacokinetics. 64(10). 1495–1506.
3.
Straumann, Isabelle, Patrick Vizeli, Anne Eckert, et al.. (2025). Acute effects of MDMA, MDA, lysine-MDMA, and lysine-MDA in a randomized, double-blind, placebo-controlled, crossover trial in healthy participants. Neuropsychopharmacology. 51(2). 476–485.
4.
Schmid, Yasmin, Felix Müller, A. Becker, et al.. (2025). Safety and Efficacy of Repeated Low-Dose LSD for ADHD Treatment in Adults. JAMA Psychiatry. 82(6). 555–555. 4 indexed citations
5.
Becker, A., Isabelle Straumann, Jan Thomann, et al.. (2025). Acute Effects and Pharmacokinetics of LSD after Paroxetine or Placebo Pre‐Administration in a Randomized, Double‐Blind, Cross‐Over Phase I Trial. Clinical Pharmacology & Therapeutics. 117(6). 1784–1792. 6 indexed citations
6.
Klaiber, Aaron, Yasmin Schmid, A. Becker, et al.. (2024). Acute dose-dependent effects of mescaline in a double-blind placebo-controlled study in healthy subjects. Translational Psychiatry. 14(1). 395–395. 12 indexed citations
7.
Müller, Lorenz, A. Becker, Aaron Klaiber, et al.. (2024). Acute dose-dependent effects and self-guided titration of continuous N,N-dimethyltryptamine infusions in a double-blind placebo-controlled study in healthy participants. Neuropsychopharmacology. 50(6). 1008–1016. 3 indexed citations
8.
Luethi, Dino, Deborah Rudin, Isabelle Straumann, et al.. (2024). Derivatization-free determination of chiral plasma pharmacokinetics of MDMA and its enantiomers. Journal of Chromatography B. 1238. 124123–124123. 5 indexed citations
9.
Ley, Laura, Isabelle Straumann, A. Becker, et al.. (2023). Acute effects of intravenous DMT in a randomized placebo-controlled study in healthy participants. Neuroscience Applied. 2. 103377–103377.
10.
Ley, Laura, Friederike Holze, A. Becker, et al.. (2023). Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants. Neuropsychopharmacology. 48(11). 1659–1667. 75 indexed citations
11.
Kolaczynska, Karolina E., et al.. (2022). Receptor Interaction Profiles of 4-Alkoxy-3,5-Dimethoxy-Phenethylamines (Mescaline Derivatives) and Related Amphetamines. Frontiers in Pharmacology. 12. 794254–794254. 11 indexed citations
12.
Rudin, Deborah, Dino Luethi, Therese Ku, et al.. (2021). Illuminating the norepinephrine transporter: fluorescent probes based on nisoxetine and talopram. RSC Medicinal Chemistry. 12(7). 1174–1186. 11 indexed citations
13.
Rudin, Deborah, Matthias E. Liechti, & Dino Luethi. (2021). Molecular and clinical aspects of potential neurotoxicity induced by new psychoactive stimulants and psychedelics. Experimental Neurology. 343. 113778–113778. 37 indexed citations
14.
Das, Anand Kant, Dino Luethi, Dániel Szöllősi, et al.. (2020). SLC6 transporter oligomerization. Journal of Neurochemistry. 157(4). 919–929. 26 indexed citations
15.
Kearney, Patrick J., et al.. (2020). Dopamine transporter trafficking and Rit2 GTPase: Mechanism of action and in vivo impact. Journal of Biological Chemistry. 295(16). 5229–5244. 25 indexed citations
16.
Mayer, Felix P., Laurin Wimmer, Dino Luethi, et al.. (2019). Stereochemistry of phase-1 metabolites of mephedrone determines their effectiveness as releasers at the serotonin transporter. Neuropharmacology. 148. 199–209. 14 indexed citations
17.
Maier, Julian, Felix P. Mayer, Dino Luethi, et al.. (2018). The psychostimulant (±)-cis-4,4′-dimethylaminorex (4,4′-DMAR) interacts with human plasmalemmal and vesicular monoamine transporters. Neuropharmacology. 138. 282–291. 16 indexed citations
18.
Luethi, Dino, Marius C. Hoener, & Matthias E. Liechti. (2017). Effects of the new psychoactive substances diclofensine, diphenidine, and methoxphenidine on monoaminergic systems. European Journal of Pharmacology. 819. 242–247. 31 indexed citations
19.
Luethi, Dino, et al.. (2017). Pharmacological profile of mephedrone analogs and related new psychoactive substances. Neuropharmacology. 134(Pt A). 4–12. 82 indexed citations
20.
Luethi, Dino, Selvi Durmuş, Alfred H. Schinkel, et al.. (2013). Liquid chromatography–tandem mass spectrometry assay for the EGFR inhibitor pelitinib in plasma. Journal of Chromatography B. 934. 22–25. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna Rickli Breakdown of academic impact, for papers by Jason Wallach Breakdown of academic impact, for papers by João Paulo Capela Breakdown of academic impact, for papers by Nicholas V. Cozzi Breakdown of academic impact, for papers by Jakub Wojcieszak Breakdown of academic impact, for papers by Eulàlia Olesti Breakdown of academic impact, for papers by Spyros P. Nikas Breakdown of academic impact, for papers by York Schramm Breakdown of academic impact, for papers by Herbert H. Seltzman Breakdown of academic impact, for papers by David L. Nelson
Rankless by CCL
2026